Drug Injury Intake: How to Qualify Pharmaceutical Liability Cases

Why Drug Injury Cases Are Different From Standard PI

The average pharmaceutical liability case takes three to five years to resolve and costs firms $100,000 to $500,000 in litigation expenses before a dollar comes in. That timeline and that exposure starts with a single phone call, and what the person on the phone captures in the first five minutes determines whether your firm takes on a winner or walks into a money pit.

Drug injury cases are not car accidents. They are not slip-and-falls. The liability chain is longer, the science is harder, and the defendants are Fortune 500 companies with legal budgets larger than most firms’ annual revenue. Whoever picks up that initial call needs to know exactly what they are listening for, because the casual question you did not ask in week one can cost you the case in year four.

Here is what makes these cases structurally different from standard personal injury:

• Multiple defendants: Manufacturer, distributor, prescribing physician, and pharmacy can all be in the chain. The person on the phone needs to capture enough detail to identify which parties are potentially liable.
• Expert-dependent liability: You cannot win a pharma case without expert witnesses connecting the drug to the injury. That connection is only possible if the medical history was documented from day one.
• Regulatory record matters: FDA adverse event reports, black box warnings, and recall histories are central to your theory of the case. A caller who mentions a drug name should prompt an immediate mental flag: has this drug been flagged?
• Causation is contested by design: Drug companies spend heavily on experts who will argue the injury had nothing to do with the medication. Your intake documentation is the foundation that makes that argument harder to sustain.
• Class action overlap: Many pharmaceutical liability cases already have active class actions or MDL proceedings. Early identification affects how you handle the case and what fee structure you can offer.

None of this requires a law degree to understand. It requires the right questions, asked consistently, on every call. For more context on how this fits into broader toxic exposure intake, see our toxic tort intake checklist.

The 5 Critical Questions to Ask on Every Pharmaceutical Liability Call

Your front desk does not need to be a pharmacologist. They need to ask five questions in the right order and write down the answers accurately. Here they are, with the exact language your team can use:

1. What drug or medical device are we talking about?

Ask: “Can you give me the exact name of the medication or device? Do you have the bottle or packaging nearby?”

The drug name is not just a data point. It is a research trigger. Certain drugs, biologics, and devices are already under active litigation or FDA scrutiny. Knowing the name in the first 60 seconds allows whoever is on the phone to flag immediately if this is a high-value case type, a class action situation, or something that requires specialized co-counsel.

2. What injury or condition are you experiencing?

Ask: “What health problems are you dealing with that you believe are connected to this medication?”

Do not let the caller give a vague answer. If they say “I got really sick,” push gently: “Can you tell me more specifically? Are we talking about a specific diagnosis, a hospitalization, an organ issue, something a doctor identified?” The injury must be documentable. Feelings of being unwell with no clinical diagnosis are very difficult to build a case around.

3. When did you start taking the medication, and when did the injury begin?

Ask: “When did you first start taking this drug? And when did you first notice these health problems?”

Temporal proximity between drug exposure and injury onset is one of the primary things a medical expert looks for. A caller who started a medication in March and had a cardiac event in April is a very different profile than someone who took a drug once five years ago and developed symptoms last week. Both may have cases. The timeline tells you where the science is likely to land.

4. Have you seen a doctor who has connected this drug to your injury?

Ask: “Has any doctor, specialist, or healthcare provider told you they believe the medication may have caused this?”

A treating physician who has already made the connection on paper is significant. It does not make or break the case, but it tells you that causation has at least been raised in a clinical setting. If no doctor has made the connection, that is not disqualifying, but it should be noted.

5. Are you still taking the medication?

Ask: “Are you currently still taking this medication, or have you stopped? If you stopped, do you remember when?”

This matters for two reasons. First, ongoing exposure affects the damages calculation and the medical narrative. Second, if the caller is still taking the drug and the injury is ongoing, they may need to be advised to speak with their prescribing physician before making changes. That is not legal advice, it is basic human responsibility. Your team should know how to handle this moment without panicking.

Red Flags That Signal a Strong Case

Not every pharma call will be a clear winner. But certain signals, heard on the first call, indicate that a case is worth aggressive pursuit. Whoever picks up should know what to listen for.

FDA Adverse Event Reports (FAERs)

The FDA’s MedWatch system publishes adverse event reports for drugs and devices. If a caller names a drug that has accumulated thousands of adverse event reports for the same injury type they are describing, that is material. Your intake process should include a simple cross-reference step: after the call, whoever handled it checks the FDA MedWatch database for the drug name plus the injury type before passing the call summary to an attorney.

Black Box Warnings

A black box warning is the FDA’s strongest safety label. If a drug the caller took carries a black box warning for the type of injury they suffered, and the caller was not informed of that risk, you have a potential failure-to-warn claim sitting in your intake queue. The front desk does not need to know this in real time. But the follow-up checklist should include this verification step.

Active Recalls or Class Actions

If the drug has been recalled or is already the subject of a federal multi-district litigation (MDL), your response changes. You may be adding this caller to an existing docket rather than opening independent litigation. That is not a lesser case. It is a different case management path, and it affects your fee agreement language from day one.

Hospitalization or Permanent Injury

The damages in pharmaceutical liability are largely driven by injury severity. A caller who was hospitalized, underwent surgery, lost a body function, or received a terminal diagnosis connected to a drug is describing a case with substantial damages potential. Your intake form should capture hospitalization dates and names of treating facilities explicitly, not just a general description of “serious injury.”

Multiple People Affected by the Same Drug

If a caller mentions they know other people who had the same reaction to the same drug, document that. It is not proof of anything, but it suggests a pattern that may already be emerging in regulatory databases or litigation.

Common Caller Scenarios and How to Handle Them

Drug injury calls do not arrive neatly labeled. Here are the most common scenarios your front desk will encounter, and what the intake conversation should look like for each.

Scenario 1: Prescribed Medication Side Effect

The caller took a medication as directed by their doctor and developed a serious health condition. The prescribing physician may or may not have warned them about the risk.

Key intake focus: Was the risk disclosed at the time of prescribing? What does the label say? Has the drug been flagged by the FDA for this type of injury? This is the most common pharma intake call and covers everything from antidepressants linked to birth defects to blood thinners linked to uncontrolled bleeding.

Scenario 2: Defective Medical Device

Hip replacements that failed prematurely. IUDs that migrated. Surgical mesh that caused chronic pain. These callers often do not identify their case as a “drug injury” but it falls under the same liability framework: a manufacturer placed a product into commerce that caused harm.

Key intake focus: Device name, manufacturer, implant date, revision or removal surgery, and treating surgeon contact information. See our product liability intake checklist for the full device-specific question set.

Scenario 3: Off-Label Use Injury

A doctor prescribed a drug for a use not approved by the FDA. The caller took it as directed and suffered a serious side effect. Off-label prescribing is legal, but manufacturers are prohibited from marketing drugs for off-label uses. If the drug company was promoting an off-label use that caused harm, that is a separate and significant liability theory.

Key intake focus: Did the doctor tell them what the drug was for? Did any marketing materials, direct-to-consumer ads, or pharmacy materials describe a use that the caller relied on? This scenario requires careful documentation because the liability chain looks different than a standard defect case.

Scenario 4: Generic Drug Confusion

A caller took a generic version of a brand-name drug. This matters because under current federal law, generic drug manufacturers have significantly limited liability exposure compared to brand-name manufacturers. Your intake team does not need to understand the Mensing doctrine. They need to capture whether the caller took the brand-name drug or the generic, and whether any brand-name drug was ever prescribed (even if the caller filled a generic). That distinction affects whether you have a viable case at all.

Documentation Your Front Desk Needs to Capture

The following information should be on your intake form for every pharmaceutical liability call. If your current form does not include these fields, update it before the next call comes in.

• Full drug or device name (brand name and generic name if known)
• Manufacturer name (as stated on the packaging, if the caller has it)
• Prescribing physician name and specialty
• Date prescription was started
• Date injury or symptoms first appeared
• Specific injury or diagnosis (exact terms, not summaries)
• Treating physicians who have connected the drug to the injury
• Hospitalization dates and facilities
• Whether the caller still has the original packaging or records
• Whether the caller is still taking the medication
• Whether the caller has spoken to any other attorneys about this matter
• How the caller heard about your firm

Every one of these fields has a downstream purpose. The packaging preserves the lot number, which is critical in defect cases. The treating physician list gives your medical expert a starting point. The “other attorneys” question tells you whether you are dealing with a comparison shopper or a first call.

For benchmarks on what a high-performing intake process looks like across case types, see our intake conversion benchmarks.

Time-Sensitivity: Statutes of Limitations and Preservation of Evidence

Pharmaceutical liability cases have two time pressures that your intake process must address on the first call, not at the first attorney meeting.

Statutes of Limitations

State statutes of limitations for product liability generally run two to three years from the date of injury, but the discovery rule complicates this in pharma cases. The clock often starts when the plaintiff knew or reasonably should have known that the drug caused the injury, not when the injury occurred. That distinction matters because a caller may have been injured years ago but only recently learned the drug was responsible.

Whoever is on the phone should ask: “When did you first connect your health problem to this medication?” That answer is not just factual context. It is a statute of limitations data point. If the caller says they made the connection two years ago and your state has a two-year statute, that is an urgent flag that needs to be passed to an attorney the same day, not the same week.

Preservation of Evidence

Tell every caller, on the first call, to keep the following:

• The original medication bottle or packaging, including the lot number
• All pharmacy receipts and prescription records
• All medical records related to the injury, including emergency room visits
• Any written communications from their doctor about the medication
• Any marketing materials, brochures, or patient guides they received

Do not assume they will figure this out. People throw away pill bottles. They lose paperwork. The person on the phone in the first call is often the only person who will ever give them this instruction. Say it plainly: “Before we do anything else, I want to make sure you hold on to everything connected to this medication. Do not throw anything away. That packaging and those records are important to your case.”

How to Handle the Emotional Caller in Pharma Cases

A caller in a pharmaceutical liability case is almost always in a different emotional state than a caller in a standard auto accident. They trusted a medical system. A doctor they believed in prescribed something. A company they assumed was regulated made it. And now they are sick, scared, and often angry in a way that feels profound and personal.

The person picking up your phone may not have an intake script for that emotional reality. Here is how to handle it.

Do not rush to qualification

The instinct, especially for a busy front desk, is to get to the facts immediately. Resist that for the first 60 to 90 seconds. Let the caller say what happened. Reflect it back briefly: “It sounds like you trusted this medication and it seriously hurt you. I am sorry you are dealing with this. I want to make sure we capture everything so we can figure out how we can help.” That one sentence does more for conversion than any script.

Acknowledge the trust violation

These callers are not just injured. They feel deceived. Acknowledging that directly, without making legal promises, matters: “You did everything right. You took a medication your doctor prescribed. What happened to you should not have happened.” This is not legal advice. It is human decency, and it keeps the caller on the phone long enough to complete the intake.

Be honest about the timeline

Pharma cases take time. Callers who are not prepared for that reality become difficult clients. The first call is the right moment to set honest expectations: “These types of cases can take longer than other injury cases because the science has to be established carefully. But that does not mean we cannot build a strong case. It means we need to be thorough from the start, which is exactly what we are doing right now.”

End with clear next steps

Never let a pharma intake call end ambiguously. The caller should leave the conversation knowing exactly what happens next: who will call them back, in what timeframe, and what they should do in the meantime (preserve the evidence). A caller who knows what comes next stays. A caller who hangs up uncertain calls a different firm.

See How eNZeTi Works in a Real Law Firm

Every question in this article is something your front desk should be asking. Most of the time, they are not, because nobody ever trained them to, and they are handling three other things while they are on the phone with a scared caller who may be worth $500,000 in contingency fees.

eNZeTi listens to pharmaceutical liability calls in real time and puts the right question on the screen at the right moment. Not after the call, when the case is already half-lost. During the call, while there is still time to ask about the lot number, the prescribing physician, the statute of limitations timeline, and whether the caller has heard of anyone else on the same drug with the same problem.

The person on the phone stays in charge. They deliver the question in their own voice with their own warmth. They still have the conversation. eNZeTi just makes sure the conversation captures everything your attorney needs to evaluate the case on day one instead of month six.

See how eNZeTi works in a real law firm. Book a Free Call Analysis at enzeti.com.